{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:04:59Z","timestamp":1789621499443,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    CBFA2T3::GLIS2-positive myeloid neoplasms occur predominantly in infants and can closely mimic pediatric small round cell sarcomas. We describe a 14-month-old boy who presented with left leg pain, an abnormal gait, and a destructive left ischial mass. Tissue biopsy was initially interpreted as an undifferentiated Ewing-like sarcoma. Bone marrow aspiration contained approximately 2% unclassified large cells, while trephine biopsy demonstrated focal tumor infiltration. Marrow tumor cells showed strong CD56 and weak CD61 expression and were positive for WT1, CD43, ERG, CD117, and BCL2. Lysozyme, MPO, TdT, and CD71 were negative. Diagnostic bone marrow flow cytometry was not performed. Molecular studies on pelvic lesion tissue showed negative results on EWSR1 break-apart fluorescence\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization (FISH). Broad RNA fusion testing detected CBFA2T3::GLIS2, joining CBFA2T3 exon 11 to GLIS2 exon 3, without a covered Ewing or Ewing-like sarcoma-defining fusion. After one cycle of cyclophosphamide, doxorubicin, and vincristine under the provisional sarcoma diagnosis, treatment was redirected to a 10-day course of cytarabine, etoposide, and daunorubicin. Severe myelosuppression was managed with anti-infective and supportive therapy. Subsequent marrow morphology, trephine biopsy, and flow cytometry showed no evident residual tumor. Follow-up MRI demonstrated marked reduction of the pelvic mass, although residual osseous abnormalities persisted. The patient subsequently continued treatment elsewhere. Available records documented additional targeted therapy and maternal haploidentical hematopoietic stem cell transplantation (HSCT). The first reported post-transplant molecular assessment detected no CBFA2T3::GLIS2 fusion transcript. Detailed post-transfer treatment parameters and long-term outcomes were unavailable. This case highlights the value of integrated tissue and marrow assessment and broad RNA fusion testing in EWSR1-negative infantile small round cell tumors.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1936497","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:48:20Z","timestamp":1789620500000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: CBFA2T3::GLIS2-positive myeloid sarcoma with focal bone marrow involvement mimicking Ewing sarcoma in an infant"],"prefix":"10.3389","volume":"16","author":[{"given":"Siman","family":"Chen","sequence":"first","affiliation":[{"name":"Clinical Laboratory, Longgang Central Hospital of Shenzhen","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Longgang Central Hospital of Shenzhen","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shenzhen Children\u2019s Hospital, Affiliated to Shantou University Medical College","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2023.04.009","article-title":"Myeloid sarcoma: an overview","volume":"40","author":"Ramia de Cap","year":"2023","journal-title":"Semin Diagn Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05288-1","article-title":"Myeloid sarcoma: more and less than a distinct entity","volume":"102","author":"Loscocco","year":"2023","journal-title":"Ann Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.10.007","article-title":"An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia","volume":"22","author":"Gruber","year":"2012","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij","year":"2017","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15725","article-title":"CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity","volume":"184","author":"Masetti","year":"2019","journal-title":"Br J Haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.119","article-title":"A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group","volume":"30","author":"Eidenschink Brodersen","year":"2016","journal-title":"Leukemia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24339","article-title":"CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript","volume":"99","author":"Zangrando","year":"2021","journal-title":"Cytometry A"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14076","article-title":"Acute myeloid leukemia with RAM immunophenotype: a new underdiagnosed entity","volume":"45","author":"Gajendra","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.741","article-title":"CBFA2T3::GLIS2-positive acute leukemia with RAM and mixed T\/megakaryocytic phenotype","volume":"4","author":"Khanlari","year":"2023","journal-title":"EJHaem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqae131","article-title":"Myeloid sarcomas with CBFA2T3 : GLIS2 fusion: clinicopathologic characterization of 4 cases mimicking small round cell tumors","volume":"163","author":"Malik","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125895","article-title":"Extramedullary relapse of CBFA2T3::GLIS2-positive megakaryoblastic leukemia mimicking secondary Ewing sarcoma: an exemplary case for the diagnostic trap","volume":"26","author":"Lebedeva","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.semdp.2014.01.002","article-title":"Ewing sarcoma","volume":"31","author":"Choi","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31824ee43c","article-title":"NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma","volume":"36","author":"Yoshida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/pin.13293","article-title":"Ewing and Ewing-like sarcomas: a morphological guide through genetically-defined entities","volume":"73","author":"Yoshida","year":"2023","journal-title":"Pathol Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2024.01.007","article-title":"Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02102-9","article-title":"Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia","volume":"38","author":"Hoffmeister","year":"2024","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01841","article-title":"Hematopoietic stem cell transplantation outcomes for high-risk AML: a report from the Children\u2019s Oncology Group","volume":"43","author":"Huang","year":"2025","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02845-7","article-title":"Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia","volume":"40","author":"Gonzales","year":"2026","journal-title":"Leukemia"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1936497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:48:44Z","timestamp":1789620524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1936497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":20,"alternative-id":["10.3389\/fonc.2026.1936497"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1936497","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1936497"}}